• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    Amicus Therapeutics, Inc. (FOLD)

    -NasdaqGM
    15.53 Up 0.64(4.30%) Sep 4, 4:00PM EDT
    |After Hours : 15.59 Up 0.06 (0.39%) Sep 4, 7:04PM EDT
    Add to Portfolio
    Prev Close:14.89
    Open:14.63
    Bid:15.37 x 100
    Ask:N/A
    1y Target Est:21.88
    Beta:2.33866
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:14.52 - 15.69
    52wk Range:5.13 - 18.83
    Volume:1,538,602
    Avg Vol (3m):2,318,540
    Market Cap:1.84B
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    FOLDUp 4.30%1.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6,028.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.19
    Quarterly EPS Est (Sep-15) :-0.24
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amicus Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutic products for rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme repla... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback